Cargando…
Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes
OBJECTIVE: To determine whether potential breast milk exposure to interferon-beta (IFN-β) or glatiramer acetate (GA) is safe for the infant. METHODS: We identified 74 infants born to 69 women with MS who breastfed under IFN-β (n = 39), GA (n = 34), or both (n = 1). Women had been enrolled into the G...
Autores principales: | Ciplea, Andrea Ines, Langer-Gould, Annette, Stahl, Anna, Thiel, Sandra, Queisser-Wahrendorf, Annette, Gold, Ralf, Hellwig, Kerstin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251509/ https://www.ncbi.nlm.nih.gov/pubmed/32434802 http://dx.doi.org/10.1212/NXI.0000000000000757 |
Ejemplares similares
-
Eighteen-month safety analysis of offspring breastfed by mothers
receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA
study
por: Ciplea, Andrea Ines, et al.
Publicado: (2022) -
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder
por: Ciplea, Andrea Ines, et al.
Publicado: (2020) -
Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy
por: Hellwig, Kerstin, et al.
Publicado: (2023) -
Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy
por: Hellwig, Kerstin, et al.
Publicado: (2022) -
The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
por: Thiel, Sandra, et al.
Publicado: (2021)